Grifols, S.A. American Depositary Receipt (GRFS) at a glance

Grifols, S.A. American Depositary Receipt (GRFS) is a mid-cap Healthcare company. It trades at $7.55, with a P/E of 10.2, a 6.1% profit margin and revenue decline of 0.9%. It pays a 1.1% dividend yield. Vestovix scores it 59/100 overall. Its strongest dimension is Value (93/100) and its weakest is Momentum (26/100). Its volatility is roughly in line with the market.

Price
$7.55
Market cap
$5.27B
P/E ratio
10.2
Dividend yield
1.15%
Beta
1.19
52-week range
$6.96 to $10.23
Vestovix Score59/ 100How this works
Value
93
Growth
63
Income
49
Safety
38
Momentum
26

Other Healthcare stocks

See all